Cartesian Therapeutics Inc (NAS:RNAC)
$ 10.88 +0.81 (+8.1%) Market Cap: 329.18 Mil Enterprise Value: 245.43 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 24/100

Cartesian Therapeutics Inc (RNAC) Transcripts

  • 1